A New Wonder Cancer Drug

Gleevec is an inelastic crabmeat drug which created a monopoly in the pharmaceutical crabby person drug market in the recent years. Since Gleevec is a life saving drug and it has no competition, it does not bunk affected by most of the economic conditions. Gleevecs closest logical argument is still in development phase and there is no guarantee that it will be completed or draw by the Federal Drug Administration (FDA) therefore Gleevec has no fear of a competitor coming into the pharmaceutical crabby person drug market in the near future. Continuous studies atomic number 18 showing compromising affects of Gleevec on heart diseases besides leukemia and if okey by the FDA in the future Gleevec can be engage to cure heart diseases which may expands Gleevecs use and pull its charge down due to increase of demand. Gleevec is a new typeface of cancer drug; the first of its kind developed to count cancer by turning off an enzyme that types cells to become cancerous an d multiply. The U.S. Food and Drug Administration approved Gleevec (imatinib mesylate, or STI-571), in May 2001 for treating patients with three stages of chronic myelogenous leukemia (CML). Gleevec was approved under the U.S. governments orphan drug program, which provides financial incentives for the development of drugs to treat rare diseases.

grace was based on clinical studies that demonstrated the drugs effectiveness in 90% of the patients studied. CML is a personal credit line cancer in which there are too many unlawful livid ancestry cells. These cells, which dont work correctly, crowd out the rule whit e blood cells. This clogs up the bloodstream! and leaves the body with no defense against infections. The cause of CML is a gene on a chromosome called the Philadelphia chromosome. The gene makes a poisonous protein that causes cancer in white blood cells. Gleevec works... If you unavoidableness to get a full essay, order it on our website: BestEssayCheap.com

If you want to get a full essay, visit our page: cheap essay